Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-31 @ 11:23 AM
Study NCT ID:
NCT00711594
Status:
COMPLETED
Last Update Posted:
2015-01-15
First Post:
2008-07-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-04
Start Date Type:
None
Primary Completion Date:
2013-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-11
Completion Date Type:
ACTUAL
First Submit Date:
2008-07-08
First Submit QC Date:
None
Study First Post Date:
2008-07-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-08-08
Results First Submit QC Date:
None
Results First Post Date:
2013-11-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-01-13
Last Update Post Date:
2015-01-15
Last Update Post Date Type:
ESTIMATED